Nav: Home

Being overweight may raise your risk for advanced prostate cancer

March 04, 2020

A new study links being overweight in middle age and later adulthood to a greater risk of advanced prostate cancer. Jeanine Genkinger, PhD, an epidemiologist at Columbia University Mailman School of Public Health, and colleagues published the study in Annals of Oncology, the journal of the European Society for Medical Oncology and Japanese Society of Medical Oncology.

Prostate cancer is the second most common cause of cancer in men in the United States. Fewer than one in three men with advanced prostate cancer live five years beyond diagnosis.

Before this study, only a few studies examined contributing factors to advanced prostate cancer. There was an especially noticeable lack of research on the linkage between factors like weight in early adulthood, changes in weight during adulthood, and waist circumference, specifically with advanced prostate cancer risk.

Using data from 15 large studies combined together, Genkinger examined associations between body fat, height, and prostate cancer risk in 830,772 men, 51,734 of whom had been diagnosed with prostate cancer. Her study took a life-course-based approach, examining survey data collected across respondents' lifespans to determine whether and at what age during adulthood excess body fat increased risk for advanced prostate cancer. The researchers found that a BMI elevated above a healthy weight during middle to late adulthood--median age range from 50 to 64--was linked to the greatest risk for developing advanced prostate cancer. A "healthy" weight is defined as a BMI between 21 and 25 kg/m2.

They also found that greater waist circumference was linked with increased risk of advanced prostate cancer and death. Although other studies have linked higher BMI with increased prostate cancer, this is the first study to find a positive association with waist circumference.

"These study results show that risk for advanced prostate cancer can be decreased by maintaining a 'healthy' weight, which is in line with guidelines by the American Cancer Society and World Cancer Research Fund. Adopting healthy eating and exercising are factors that can help maintain a healthy weight," says Genkinger, associate professor of epidemiology at Columbia Mailman School. "This study shows that adopting and maintaining healthy weight in middle to late adulthood can especially reduce risk of advanced prostate cancer."
-end-
Participating institutions include Mailman School of Public Health, Columbia University Medical Center, Harvard TH Chan School of Public Health, Harvard Medical School, National Cancer Institute, Maastricht University, American Cancer Society, Cancer Council Victoria, University of Melbourne, Fred Hutchinson Cancer Research Center, SWOG Statistical Center, Karolinska Institutet, University of Oxford, Finland National Institute for Health and Welfare, University of Hawaii Cancer Center, Johns Hopkins Bloomberg School of Public Health, Japan National Cancer Center, Uppsala University. A full list of authors is listed in the publication.

This study was funded by the National Cancer Institute at the National Institutes of Health (CA098566, CA55075), and the World Cancer Research Fund International (grant 2009/89).

Columbia University's Mailman School of Public Health

Related Prostate Cancer Articles:

The Lancet: Prostate cancer study finds molecular imaging could transform management of patients with aggressive cancer
Results from a randomised controlled trial involving 300 prostate cancer patients find that a molecular imaging technique is more accurate than conventional medical imaging and recommends the scans be introduced into routine clinical practice.
Common genetic defect in prostate cancer inspires path to new anti-cancer drugs
Researchers found that, in prostate cancer, a mutation leading to the loss of one allele of a tumor suppressor gene known as PPP2R2A is enough to worsen a tumor caused by other mutations.
First prostate cancer therapy to target genes delays cancer progression
For the first time, prostate cancer has been treated based on the genetic makeup of the cancer, resulting in delayed disease progression, delayed time to pain progression, and potentially extending lives in patients with advanced, metastatic prostate cancer, reports a large phase 3 trial.
Men taking medications for enlarged prostate face delays in prostate cancer diagnosis
University of California San Diego School of Medicine researchers report that men treated with medications for benign prostatic hyperplasia (enlarged prostate) experienced a two-year delay in diagnosis of their prostate cancer and were twice as likely to have advanced disease upon diagnosis.
CNIO researchers confirm links between aggressive prostate cancer and hereditary breast cancer
The study has potential implications for families with members suffering from these types of tumours who are at an increased risk of developing cancer.
Distinguishing fatal prostate cancer from 'manageable' cancer now possible
Scientists at the University of York have found a way of distinguishing between fatal prostate cancer and manageable cancer, which could reduce unnecessary surgeries and radiotherapy.
Researchers find prostate cancer drug byproduct can fuel cancer cells
A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to new research at Cleveland Clinic.
ASCO and Cancer Care Ontario update guideline on radiation therapy for prostate cancer
The American Society of Clinical Oncology (ASCO) and Cancer Care Ontario today issued a joint clinical practice guideline update on brachytherapy (internal radiation) for patients with prostate cancer.
Patient prostate tissue used to create unique model of prostate cancer biology
For the first time, researchers have been able to grow, in a lab, both normal and primary cancerous prostate cells from a patient, and then implant a million of the cancer cells into a mouse to track how the tumor progresses.
Moffitt Cancer Center awarded $3.2 million grant to study bone metastasis in prostate cancer
Moffitt researchers David Basanta, Ph.D., and Conor Lynch, Ph.D., have been awarded a U01 grant to investigate prostate cancer metastasis.
More Prostate Cancer News and Prostate Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.